No association between Vitamin D receptor gene polymorphisms and nasopharyngeal carcinoma in a Chinese Han population

BioScience Trends

Volumn 5, Issue 3, 2011, Pages 99-103

  Huang, Xin ^a,b   Cao, Zhiling ^b   Zhang, Zhen ^a   Yang, Yang ^b   Wang, Jun ^b   Fang, Dingzhi ^a  

^a SICHUAN UNIVERSITY   (China)

^b First People's Hospital of Leshan   (China)

Author keywords

Gene polymorphism; Nasopharyngeal carcinoma; Vitamin D receptor

Indexed keywords

CALCITRIOL RECEPTOR;

ADULT; ARTICLE; ASIAN; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MIDDLE AGED; NASOPHARYNX CARCINOMA; NASOPHARYNX TUMOR;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL;

EID: 84863116428     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: 10.5582/bst.2011.v5.3.99     Document Type: Article

References (30)

1. McDermott AL, Dutt SN, Watkinson JC. The aetiology of nasopharyngeal carcinoma. Clin Otolaryngol Allied Sci. 2001; 26:82-92.
2. Li LD, Rao KQ, Zhang SW, Lu FZ, Zhou XN. Statistical analysis of data from 12 cancer registries in China, 1993-1997. Bull Chin Cancer. 2003; 11:497-507. (in Chiese)
3. Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2006; 15:1765-1777.
4. Hsu WL, Chen JY, Chien YC, Liu MY, You SL, Hsu MM, Yang CS, Chen CJ. Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: A 20-year follow-up study on 9,622 males without family history in Taiwan. Cancer Epidemiol Biomarkers Prev. 2009; 18:1218-1226.
5. Guo X, O'Brien SJ, Zeng Y, Nelson GW, Winkler CA. GSTM1 and GSTT1 gene deletions and the risk for nasopharyngeal carcinoma in Han Chinese. Cancer Epidemiol Biomarkers Prev. 2008; 17:1760-1763.
6. Jia WH, Pan QH, Qin HD, Xu YF, Shen GP, Chen L, Chen LZ, Feng QS, Hong MH, Zeng YX, Shugart YY. A Case-control and a family-based association study revealing an association between CYP2E1 polymorphisms and nasopharyngeal carcinoma risk in Cantonese. Carcinogenesis. 2009; 30:2031-2036.
7. Zhu Y, Xu Y, Wei Y, LiangW, Liao M, Zhang L. Association of IL-1B gene polymorphisms with nasopharyngeal carcinoma in a Chinese population. Clin Oncol (R Coll Radiol). 2008; 20:207-211.
8. Wei YS, Lan Y, Tang RG, Xu QQ, Huang Y, Nong HB, Huang WT. Single nucleotide polymorphism and haplotype association of the interleukin-8 gene with nasopharyngeal carcinoma. Clin Immunol. 2007; 125:309-317.
9. Mullin GE, Dobs A. Vitamin D and its role in cancer and immunity: A prescription for sunlight. Nutr Clin Pract. 2007; 22:305-322.
10. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004; 338:143-156.
11. Zmuda JM, Cauley JA, Ferrell RE. Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev. 2000; 22:203-217.
12. Guy M, Lowe LC, Bretherton-Watt D, Mansi JL, Peckitt C, Bliss J, Wilson RG, Thomas V, Colston KW. Vitamin D receptor gene polymorphisms and breast cancer risk. Clin Cancer Res. 2004; 10:5472-5481.
13. Xu Y, Shibata A, McNeal JE, Stamey TA, Feldman D, Peehl DM. Vitamin D receptor start codon polymorphism (Fok1) and prostate cancer progression. Cancer Epidemiol Biomarkers Prev. 2003; 12:23-27.
14. Slattery ML, Herrick J, Wolff RK, Caan BJ, Potter JD, Sweeney C. CDX2 VDR Polymorphism and Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. 2007; 16:2752-2755.
15. Gross C, Eccleshall TR, Malloy PJ, Villa ML, Marcus R, Feldman D. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res. 1996; 11:1850-1855.
16. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA. Prediction of bone density from vitamin D receptor alleles. Nature. 1994; 367:284-287.
17. Huang CM, Wu MC, Wu JY, Tsai FJ. No association of vitamin D receptor gene s t a r t codon fok 1 polymorphisms in Chinese patients with systemic lupus erythematosus. J Rheumatol. 2002; 29:1211-1213.
18. Ban Y, Taniyama M, Ban Y. Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population. J Clin Endocrinol Metab. 2000; 85:4639-4643.
19. Peters U, McGlynn KA, Chatterjee N, Gunter E, Garcia-Closas M, Rothman N, Sinha R. Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2001; 10:1267-1274.
20. Ntais C, Polycarpou A, Ioannidis JP. Vitamin D receptor gene polymorphisms and risk of prostate cancer: A meta-analysis. Cancer Epid Biomarkers Prev. 2003; 12:1395-1402.
21. Cheteri MB, Stanford JL, Friedrichsen DM, Peters MA, Iwasaki L, Langlois MC, Feng Z, Ostrander EA. Vitamin D receptor gene polymorphism and prostate cancer risk. Prostate. 2004; 59:409-418.
22. Buyru N, Tezol A, Yosunkaya-Fenerci E, Dalay N. Vitamin D receptor gene polymorphisms in breast cancer. Exp Mol Med. 2003; 35:550-555.
23. Oakley-Girvan I, Feldman D, Eccleshall TR, Gallagher RP, Wu AH, Kolonel LN, Halpern J, Balise RR, West DW, Paffenbarger RS, Whittemore AS. Risk of early-onset prostate cancer in relation to germline polymorphisms of the vitamin D receptor. Cancer Epidemiol Biomarkers Prev. 2004; 13:1325-1330.
24. Bodiwala D, Luscombe CJ, French ME, Liu S, Saxby MF, Jones PW, Fryer AA, Strange RC. Polymorphisms in the vitamin D receptor gene, ultraviolet radiation, and susceptibility to prostate cancer. Environ Mol Mutagen. 2004; 43:121-127.
25. Hutchinson PE, Osborne JE, Lear JT, Smith AG, Bowers PW, Morris PN, Jones PW, York C, Strange RC, Fryer AA. Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin Cancer Res. 2000; 6:498-504.
26. Ingles SA, Garcia DG, Wang W, Nieters A, Henderson BE, Kolonel LN, Haile RW, Coetzee GA. Vitamin D receptor genotype and breast cancer in Latinas (United States). Cancer Causes Control. 2000; 11:25-30.
27. Habuchi T, Suzuki T, Sasaki R, Wang L, Sato K, Satoh S, Akao T, Tsuchiya N, Shimoda N, Wada Y, Koizumi A, Chihara J, Ogawa O, Kato T. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population. Cancer Res. 2000; 60:305-308.
28. Chen WY, Bertone-Johnson ER, Hunter DJ, Willett WC, Hankinson SE. Associations between polymorphisms in the vitamin D receptor and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2005; 14:2335-2339.
29. Chaimuangraj S, Thammachoti R, Ongphiphadhanakul B, Thammavit W. Lack of association of VDR polymorphisms with Thai prostate cancer as compared with benign prostate hyperplasia and controls. Asian Pac J Cancer Prev. 2006; 7:136-139.
30. Li C, Liu Z, Wang LE, Gershenwald JE, Lee JE, Prieto VG, Duvic M, Grimm EA, Wei Q. Haplotype and genotypes of the VDR gene and cutaneous melanoma risk in non-Hispanic whites in Texas: A case-control study. Int J Cancer. 2008; 122:2077-2084.